BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18204939)

  • 1. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.
    Boyer O; Moulder JK; Grandin L; Somers MJ
    Pediatr Nephrol; 2008 Apr; 23(4):575-80. PubMed ID: 18204939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
    Elmas AT; Tabel Y; Elmas ON
    Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J; Kryński J
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K; Müller-Berghaus J; Fuchshuber A; Michalk D; Querfeld U
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise?
    Davin JC; Merkus MP
    Pediatr Nephrol; 2005 Jan; 20(1):10-4. PubMed ID: 15378419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
    Bagga A; Sharma A; Srivastava RN
    Pediatr Nephrol; 1997 Aug; 11(4):415-7. PubMed ID: 9260236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report.
    Aoun B; Alali M; Degheili JA; Sanjad S; Vaquin C; Donadieu J; Ulinski T; Termos S
    J Med Case Rep; 2018 Jul; 12(1):209. PubMed ID: 30008268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F; Ahmed TM; Samina U
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.